Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2010-12-20
2011-12-13
Chung, Susannah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S381000, C548S235000, C548S250000
Reexamination Certificate
active
08076364
ABSTRACT:
The present invention relates to a compound of the general formula (1):wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted phenyl group, and the like; R1is an optionally substituted alkyl group, and the like; and R2is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.
REFERENCES:
patent: 5536718 (1996-07-01), Albright et al.
patent: 6685617 (2004-02-01), Blinn et al.
patent: 7332514 (2008-02-01), Maeda et al.
patent: 7906517 (2011-03-01), Nakamura et al.
patent: 2002/0156281 (2002-10-01), Booth et al.
patent: 2005/0059810 (2005-03-01), Maeda et al.
patent: 2010/0167986 (2010-07-01), Ali et al.
patent: 0 129 433 (1984-06-01), None
patent: 1 426 360 (2004-06-01), None
patent: 1 533 292 (2005-05-01), None
patent: 2003-221376 (2003-08-01), None
patent: WO 00/17164 (2000-03-01), None
patent: WO 00/17165 (2000-03-01), None
patent: WO 00/17166 (2000-03-01), None
patent: WO 03/063868 (2003-08-01), None
patent: WO 2004/020393 (2004-03-01), None
patent: WO 2005/100298 (2005-10-01), None
patent: WO 2006/056854 (2006-06-01), None
patent: WO 2006/073973 (2006-07-01), None
patent: WO 2007-041494 (2007-04-01), None
Office Action for Application No. 06816017.5, dated Nov. 17, 2009.
Office Action in European Application No. 06816017.5, dated Nov. 2, 2010.
Response for European Application No. 6816017.5, dated May 27, 2010.
U.S. Office Action for U.S. Appl. No. 11/922,816, dated Oct. 13, 2010.
English Translation of International Preliminary Report on Patentability, PCT/JP2007/051861, Aug. 5, 2008.
International Search Report, PCT/JP2007-051861, Dec. 6, 2007.
Massa et al., “Novel Heteroaryl Replacements of Aromatic 2-Tetrafluoroethoxy Substitutents in Trifluoro-3-(tertiaryamino)-2-propanols as Potent Inhibitors of Cholesteryl Ester Transfer Protein”, Biorganic & Medicinal Chemistry Letters, vol. 11, pp. 1625-1628, 2001.
Hayashi Norimitsu
Higashijima Takanori
Kubota Hitoshi
Nakamura Yoshinori
Oka Kozo
Birch & Stewart Kolasch & Birch, LLP
Chung Susannah
Mitsubishi Tanabe Pharma Corporation
LandOfFree
Trisubstituted amine compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trisubstituted amine compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trisubstituted amine compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4305000